| mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.9 |
| mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
CGP-082996 |
GDSC1000 |
pan-cancer |
AAC |
-0.0089 |
0.9 |
| mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.0091 |
0.9 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |